DIA Canadian Annual Meeting

The Canadian Annual Meeting now includes a track for Pharmacovigilence and Risk Management Strategies!

Back to Agenda

Session 2 Track C: Round Table on GVP Inspections

Session Chair(s)

Agnes Jankowicz, MS

Vice President, Pharmacovigilance

Veristat, Canada

The Good Pharmacovigilance Practices (GVP) Inspection program is intended to verify that health product manufacturers meet the requirements of the Food and Drug Regulations pertaining to ADR reporting. In this session, you will learn from the Inspectorate about GVP inspection trends observed during the fiscal year 2020-2021 and on-going initiatives within the Program.

Learning Objective : At the conclusion of this session, participants should be able to:
Identify most common inspection findings observed in recent Health Canada GVP inspections

Understand what is expected during Health Canada GVP inspections

Understand how to best prepare for a GVP inspection

Speaker(s)

Speaker

Marc-André Giguère

Health Canada, Canada

Senior Policy Analyst

Have an account?